Difference between revisions of "Team:Bielefeld-CeBiTec/Results/toolbox/analysing"

Line 38: Line 38:
 
</article>
 
</article>
  
−
<div class="figure large">
+
<div class="figure medium">
 
<img class="figure image" src="https://static.igem.org/mediawiki/2017/a/a2/T--Bielefeld-CeBiTec--SVI-Analysing-results-1.png">
 
<img class="figure image" src="https://static.igem.org/mediawiki/2017/a/a2/T--Bielefeld-CeBiTec--SVI-Analysing-results-1.png">
 
<p class="figure subtitle"><b>Figure 1:</b>Alignment of the amino acid sequence of PrK-aaRS and the wildtype <i>methanosarzia mazei</i> Pyl-RS.</p>
 
<p class="figure subtitle"><b>Figure 1:</b>Alignment of the amino acid sequence of PrK-aaRS and the wildtype <i>methanosarzia mazei</i> Pyl-RS.</p>
Line 52: Line 52:
 
</div>
 
</div>
  
−
<div class="figure large">
+
<div class="figure medium">
 
<img class="figure image" src="https://static.igem.org/mediawiki/2017/2/27/T--Bielefeld-CeBiTec--SVI-Analysing-results-3.png">
 
<img class="figure image" src="https://static.igem.org/mediawiki/2017/2/27/T--Bielefeld-CeBiTec--SVI-Analysing-results-3.png">
 
<p class="figure subtitle"><b>Figure 3:</b> Alignment of the amino acid sequence of the evolved AcF-aaRS and the wildtype TyrRS from <i>methancoccus jannaschii</i>.</p>
 
<p class="figure subtitle"><b>Figure 3:</b> Alignment of the amino acid sequence of the evolved AcF-aaRS and the wildtype TyrRS from <i>methancoccus jannaschii</i>.</p>

Revision as of 10:53, 1 November 2017

Analyzing

Short Summary

The analysis tool gives the opportunity to measure intermolecular distances with the help of Foerster resonance energy transfer (FRET) in the target protein. We provide three tRNA/aminoacyl-synthetases (aaRS) for the incorporation of non-canonical amino acids (ncAAs) with additional functional groups to the canonical amino acids. The functional groups could form a covalent bond to a fluorophore in chemical reactions. The fluorescence of the fluorophores indicates how far the distance to each other is. With this tool, target proteins could be labeled at specific positions to find out if the folding of the protein changes, give information about the protein structure or if two different proteins interact. To demonstrate this tool, we labeled the yeast prion sup35 at specific positions. During translation of Sup35, two different orthogonal tRNA/aaRS incorporate two different ncAAs which can be labeled specific with fluorophores. With this test protein, applications like a quick prion detection assay are possible.

Evolved Synthetases for the Incorporation of Propargyllysine and p-Acetophenylalanine

For our toolkit we decided to use the non-canonical amino acids p-acetophenylalanine (AcF) with a ketone group and propargyllysine (PrK) with a propargyl group. Propargyl groups can be used to form a covalent bond to azide groups in a click-chemistry reaction and ketone groups could form a covalent bond to hydrazide groups. Our aim was to provide two orthogonal tRNA/aminoacyl-synthetases (aaRS) which could incorporate these amino acids through the amber codon. Furthermore, we want to provide an aaRS which incorporates AcF through the less used leucine codon (CTA). This way, both amino acids could be incorporated simultaneously and at a specific position during translation.
We received plasmids from the Lemke group from EMBL in Heidelberg containing an evolved tyrosyl tRNA/ synthtase pair (tRNA/TyrRS) from Methanococcus jannaschii for the incorporation of AcF and an evolved pyrrolysyl synthetase from Methanosarcina mazei for the incorporation of PrK, both in response to the amber codon. We used Gibson assembly to clone the tRNA/aaRS and the tRNA from these plasmids into pSB1C3 and replaced cutting sites for EcoRI and SpeI with site directed mutagenesis to provide these synthetases for the iGEM community. Furthermore, we changed the anticodon in the tRNA of the TyrRS tRNA to the anticodon for the less used leucine codon, so the new aaRS incorporates AcF in response to the codon CTA. An alignment of both evolved synthetases with the wildtypes is shown in figure 1 (PrK-aaRS) and 3(AcF-aaRS).

Figure 1:Alignment of the amino acid sequence of PrK-aaRS and the wildtype methanosarzia mazei Pyl-RS.

The alignment of the wildtype PylRS from methanosarzia mazei and the evolved synthetase for the incorporations of PrK shows only one amino acid exchange at position 124. Although this is the aaRS with the least amino acid exchanges of our toolkit, it turned out to be the most specific. We proved the incorporation of PrK through this synthetase with our screening system for the incorporation of ncAAs. The results from our screening system, which compares the incorporation efficiency and specify, are shown in figure 2. For more details of our screening method, please refer to the part improvement page.

Figure 2: Comparison of the incorporation rate of PrK and native amino acids through the evolved PrK-aaRS.

Figure 3: Alignment of the amino acid sequence of the evolved AcF-aaRS and the wildtype TyrRS from methancoccus jannaschii.

Because of the recommendation of our expert Iker Valle Aramburu, we decided to use only one ncAA to label our test protein and label the second fluorophore through maleimide labeling to a cysteine. This labeling strategy could only be used for proteins that are cysteine free or in which all cysteines could be replaced. Because this is only possible in a few applications we decided to provide a second evolved aaRS for the incorporation of AcF in response to the less used leucine codon CUA. The sequence of the synthetase is similar to the aaRS described by Kim 2012 to incorporate AcF in response to CUA .

Construction of the Expression Plasmid for the Sup35 Test Protein

For our test protein, we decided to order a gene synthesis of the NM-region of sup35. The NM region is 250 amino acids long and responsible for the prion forming function of Sup35. The test protein contains an amber codon at position 21 and one cysteine codon at position 121.
According to our expert Iker Valle Aramburu, the incorporation of two noncanonical amino acids lowers the yield. He recommended us to use only one non-canonical amino acid and one cysteine, which could be labeled in a maleimide coupling reaction. Mukhopadayay 2006 showed that mutants of Sup35 containing no cysteines are still able to form prions. So, we decided to order a gene synthesis of sup35 containing no cysteines.
For our experiments we cloned the gene synthesis of the NM region of Sup35 into pSB1C3 and used site directed mutagenizes to construct the part BBa_K2201231 containing a histag, one amber codon at position 21 and a cysteine codon at position 121. The control BBa_K2201232 contains cysteine codons at positions 21 and 121. In addition, we constructed these three parts also with a T7-promotor and RBS (BBa_K2201331 and BBa_K2201332), for the inducible expression of the Sup35 variants.

Expression and Analysis of the Sup35 Test Protein

The expression plasmid of Sup35 containing one amber stop codon at position 21 (BBa_K2201331) was cotransformed with the evolved PylRS synthetase for the incorporation of PrK (BBa_K2201201). The cells containing both plasmids were cultivated like described in expression of recombinant proteins, without PrK in the media and with 1 mM PrK in the media. Sup35 was purified through NiNTA chromatography. As positive control Sup35 without stop codons was expressed and purified the same way. All three samples were analyzed on the SDS-PAGE shown in figure 4.
Figure 4: SDS-PAGE of the eluates of the three cultivations. The positive control (PC: BBa_K220302) left and BBa_K2201301 without PrK (-PrK) in the media in the middle and with 1 mM PrK (+PrK) in the media on the right side.

The SDS-PAGE confirmed the results from our screening system. The positive control showed a high expression of the recombinant Sup35 and both samples with BBa_K2201301 showed a band on the same height as the positive control. This proved that the PrK-aaRS incorporates endogenous amino acids if PrK is not supplemented in the media. But if PrK is present the expression of Sup35 is stronger. The affinity of PrK-aaRS to PrK seems to be stronger than to the endogenous amino acids, so the test protein is expressed with the non-canonical amino acid as planned.

Labeling of the Sup35 Test Protein

The labeling of the test protein was performed in a two-step reaction. The first step was the click chemistry reaction to label the PrK with Cyanin3-azide and the second the maleimide labeling of the cysteine with Cy5 maleimide. The click chemistry reaction of 50 nMol test protein in 100 µL reaction volume was performed in 1x PBS buffer containing 200 µM copper sulfate and 200µM TCEP to prevent Sup35 to aggregate. To start the reaction 100 nMol of Cy3-azide and 200 µM freshly prepared sodium ascorbate were added and after that, the reaction was incubated 2 h at room temperature. After the incubation the Cy3-labeled test protein was washed with maleimide labeling buffer (2x PBS and 8 M guanidine hydrochlorid) and concentrated down to 50 µL by centrifugal filters. To start the maleimide labeling reaction, 100 nMol of Cy5-aleimide were added to the test protein and incubated for 2 h at room temperature. After this step the excess dye should be washed away by centrifugal filters or dialyses and the labeling was confirmed by a fluorescence scan of a SDS-PAGE containing the labeled sample and a negative control. The SDS-PAGE of our test protein before and after the labeling reaction is shown in Figure 5. Furthermore, we wanted to detect the labeling efficiency through UV-VIS spectralphotometer, but the results indicate that a high excess of free Cy5 remains in the sample and the background was too high to perform FRET-measurements. To investigate the labeling efficiency and to get a fluorescence signal the labeling reaction and especially the last washing step needs to be improved to generate suitable test protein for the prion detection assay.
Figure 5:SDS-PAGE and fluorescence scan of the SDS-PAGE of the unlabeled and labeled Sup35.

The fluorescence scan proves the successful labeling of Sup35 with Cy3 and Cy5. However, in the SDS page a second higher band appears, that seemed to be labeled too. One explanation would be that Sup35 forms aggregates in the labeling reaction. If the test protein is changed to its prionic form it would not be suitable for a prion detection assay. To investigate if Sup35 forms aggregates after the labeling reaction we wanted to check if there are any aggregates through atomic force microscopy (AFM). If there are any prion forming ability, the proteins should form big aggregates like reported by iGEM Kent 2015, who wanted to form nanowires out of Sup35. The AFM images were generated in the Experimental Biophysics & Applied Nanosciences research group from Bielefeld university, Department of Physics with an MultiMode® AFM (Bruker) in tapping mode. The images from the unlabeled and labeled Sup35 are shown in figure 6.
Figure 6:Atomic force microscopy (AFM) images of the unlabeled Sup35 (left) and the labeled Sup35 (right). The AFM images were generated in the Experimental Biophysics & Applied Nanosciences research group from Bielefeld university, Department of Physics with an MultiMode® AFM (Bruker) in tapping mode.

The AFM pictures of Sup35 (figure 6) show no form of aggregated or denaturized proteins, thus our labeling tool is suitable for the specific labeling of protein without changing their conformation. For the further development of the assay, the labeling and washing method needs to be improved regarding the remaining free dye in the samples after the labeling reactions to get a FRET signal.

References

Mukhopadhyay, S., Krishnan, R., Lembke, E. A., Lindquist, S., Deniz, A. A.(2007)A natively unfolded yeast prion monomer adopts an ensemble of collapsed and rapidly fluctuating structures.PNAS.104(8):2649-2654.